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Background: Vocal fold fibroblast’s (VFF) strategic location in the lamina propria and their ability to respond to
external stimuli by producing inflammatory molecules suggest their possible direct involvement in innate immunity.
Toll-like receptors (TLRs) are an essential signaling component to this response, as they allow for recognition of
various microorganisms, leading to subsequent induction of pro-inflammatory genes. The objective of this study
was to elucidate the role of VFF in the host immune response and subsequent influence on inflammatory
cytokine secretion.
Methods: VFF derived from polyp, scar, and normal tissue were treated with 5 μg/ml lipopolysaccharide (LPS). TLR1
through 9, CD14, and MD-2 were measured during stable conditions by polymerase chain reaction (PCR). Expression
of TLR4 and IL-1R type-1 genes were quantified after 24 hrs LPS stimulation by reverse transcription-PCR. LPS
responsiveness was determined by NF-κB nuclear translocation as measured by subunit p65 expression in nucleus
with immunocytochemistry. Downstream effects were confirmed with immunoassay measuring IL-8 concentrations
in supernatant after 8 hrs.
Results: All VFFs constitutively expressed TLR1 to 6, TLR9, CD14, and MD-2 mRNA. Polyp VFF exhibited significantly
higher TLR4 transcript levels (p < 0.001) in comparison to scar and normal VFF. LPS stimulated scar and polyp VFF
exhibited increased levels of p65 in the nucleus (p < 0.01) and secreted greater IL-8 protein (p < 0.0001) compared
to normal VFF.
Conclusion: VFF constitutively express genes for the receptors essential to the host immune response. Scar and
polyp VFF produced greater LPS responsiveness resulting in over-activated inflammatory patterns. These findings
support VFF role in the pathogenesis of inflammatory vocal fold disorders and suggests their presence in the
wound bed could lead to chronic inflammation.
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Chronic trauma to the vocal folds from vocal use, reflux,
bacteria, or viral pathogens can influence inflammation
and tissue repair, contributing to the pathophysiology of
benign vocal fold lesions [1-3]. Recent evidence has
suggested that exposure to these types of challenged
microenvironments can cause vocal fold fibroblasts
(VFF) to undergo behavior changes that can alter their
inflammatory phenotype [4]. In the vocal folds, fibro-
blasts are highly abundant and strategically located in
the most superficial layer of the lamina propria [5]* Correspondence: thibeaul@surgery.wisc.edu
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unless otherwise stated.where infection or physical damage occurs. Although
VFF are known to be involved in tissue homeostasis
[6,7] and immune cell regulation [8] their ability to
directly recognize immune challenges remains unclear.
Whether this response differs between normal cells and
those taken from inflammatory or scarred vocal fold le-
sions also warrants investigation, as a possible diagnostic
or therapeutic target.
For fibroblasts to directly contribute to the innate im-
mune response they require pattern-recognition recep-
tors (PRR) such as Toll-like receptors (TLR), which bind
to the repetitive structural components on the outer
layer of microorganisms. PRR provide an element of spe-
cificity to innate immune cells as they help distinguishis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gene rearrangement and clonal expansion (i.e. adaptive
immunity). TLRs are an essential signaling component of
the innate immune response, because ligand binding acti-
vates the transcriptional factor nuclear factor (NF)-ĸB
leading to the induction of pro-inflammatory cytokine
genes (i.e. IL-8) that can regulate the response to infection
[9]. The NF-κB protein consists of a heterodimer (p65/
p50), which is constitutively localized to the cytoplasm by
its inhibitor, IκBα while the inflammatory stimulus in-
duced degradation of IκBα allows NF-κB to translocate to
the nucleus for the de novo synthesis of genes regulating
inflammation. To date, ten members of the human TLR
family have been identified (labeled 1–10) with nine of
these receptors having known ligands such as, bacteria
(TLR2, 4 & 6), fungi (TLR5 & 6), and viruses (TLR7 & 8).
TLRs are transmembrane proteins with leucine rich repeat
domains in the extracellular region and intracellular Toll/
IL-1 receptor (TIR) domain in the cell’s intracellular com-
partment. TLR4 is the most researched and several differ-
ent stromal and immune cells express its functional form,
including fibroblasts and epithelial cells [10,11]. It can play
a critical role during host defense, because of its recogni-
tion of gram-negative bacteria and endogenous ligands
expressed after tissue injury. Additionally, recent evidence
has shown that TLR4 gene and protein levels are upregu-
lated in fibroblasts taken from hypertrophic scars [12].
There is increasing clinical evidence to support the
link between bacterial flora and benign vocal fold
lesions, such as polyps [2]. For instance, helicobacter
pylori a gram-negative bacteria is most commonly found
in the stomach, but evidence has shown its laryngeal
presence in patients diagnosed with vocal fold polyps
[1]. Host responsiveness to this unusual microbe in the
larynx is unclear. TLR4 and its accessory molecules
CD14 and MD2 recognize and respond to the cell wall
of gram-negative bacteria, which is composed of a dis-
tinct lipopolysaccharide (LPS) chain [13]. Recent work
by our group has analyzed VFF influence on the func-
tion of surrounding immune cells after exposure to LPS
[8]. We demonstrated that VFF derived from polyp, scar,
and normal tissue can modulate macrophages paracrine
signaling during early cytokine expression (i.e. TNF-α,
IL-10, IL-12) and subsequent chemokine and growth
factor expression (i.e. IL-6, IL-8, MCP-1, TGF-β). This
work suggests that VFF are a component of the innate
immune response capable of determining the quantity
and duration of macrophages response [8]. However,
VFF direct contribution in regulating host defense re-
mains undefined.
The objective of the present in vitro study was to
elucidate the role of VFF in the host immune response
and subsequent influence on inflammatory cytokine se-
cretion. First, we hypothesized that VFF constitutivelyexpress TLRs and TLR4 accessory genes, which are
required for direct recognition of various viral and
bacterial pathogens and foreign antigens. Second, we hy-
pothesized that VFF derived from polyp and scar tissue
produce functional TLR4 after ligand stimulation result-
ing in high cytokine secretion downstream where as
normal VFF are minimally responsive to stimuli.
Methods
Vocal fold fibroblasts
Human fibroblasts cell lines were derived from polyp,
scar, and two age-matched normal vocal fold tissue sam-
ples based on protocols approved by the University of
Wisconsin Health Sciences Institutional Review Board as
previously described [8,14,15]. Cells were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS), 100 U/mL
penicillin, 0.01 mg/mL streptomycin sulfate and 1× non-
essential amino acid (all from Sigma Inc, St Louis) at
37°C in atmosphere of 5% CO2. Fibroblasts were used
between passages five and nine.
RNA isolation
Normal (T21 and T59), polyp, and scar VFF were seeded
in triplicate on 6-well plates at 3 × 105 per well (Becton
Dickinson Labware) and cultured until 80% confluent.
Cells were then treated with or without 5 μg/mL LPS (γ-
irradiated, escherichia coli O26:B6, Sigma-Aldrich, USA)
for 24 hrs. Total cellular RNA was extracted from VFF
using Rneasy Mini Kit (Qiagen, Valencia, CA) according
to the manufacturer’s instructions and as previously de-
scribed [16]. First strand cDNA was synthesized from 1 μg
of total RNA using an Omniscript Reverse Transcription
Kit (Qiagen) and random primers (Integrated DNA
Technologies, Coralville, IA).
Polymerase chain reaction for transcription of TLRs and
TLR4 accessory molecules
To determine if VFF express genes necessary for patho-
gen recognition, we measured the gene expression of
nine TLRs and TLR4 accessory molecules CD14 and
MD-2 during steady state conditions. GoTaq Hot Start
Polymerase (Promega Corporation, Madison, WI) was
used with the PTC- 200 Peltier Thermal Cycler accord-
ing to the manufacturer’s protocol. Primer sequences,
gene bank access numbers, and expected PCR product
sizes are listed in Table 1. Specificity of each primer pair
was confirmed by showing a single peak and appropriate
sized DNA band for each gene product. Amplifications
were optimized for each primer and carried out for
40 cycles: denaturing at 95°C for 30 seconds, primer spe-
cific annealing temperature for 45 seconds (Table 1),
and extension at 72°C for 2 minutes. Reaction yields
were determined by electrophoresis on 2% agarose gel
Table 1 Primer Sequence and Products of Polymerase chain reaction (PCR)
Name GenBank # Forward Reverse Size
TLR- 1 NM_003263 CTATACACCAAGTTGTCAGC GTCTCCAACTCAGTAAGGTG 220
TLR- 2 NM_003264 ACCTGTCCAACAACAGGATCACCT TGTTCAAGACTGCCCAGGGAAGAA 139
TLR- 3 NM_003265 ACTGAACCATGCACTCTGTTTGCG TGACGAAAGGCACCTATCCGTTCT 96
TLR- 4 NM_138554 ATGCAGGGCTGCTAATCTCAAGGA GTTGGTTGAAATGCCCACCTGGAA 93
TLR- 5 NM_003268 GTTGCAACTTGCCTGGGAAACTGA TCAGCCTGTTGGAGTTGAGGCTTA 164
TLR- 6 NM_006068 AGGTGCCTCCATTATCCTCA GAATCCATTTGGGAAAGCAG 211
TLR- 7 NM_016562 AATGTCACAGCCGTCCCTACTGTT TTTACACGGCGCACAAGGAAATGG 180
TLR- 8 NM_138636 TGTCTCAGAGGCTGCAATGTAGGT AGGCTCGCATGGCTTACATGAGTA 136
TLR- 9 NM_017442 ATCTGCACTTCTTCCAAGGCCTGA AGAAGGCCAGGTAATTGTCACGGA 144
IL-1R, type 1 NM_000877.2 AGAGGAAAACAAACCCACAAGG CTGGCCGGTGACATTACAGAT 106
MD-2 NM_015364.4 TTGCCGAGGATCTGATGA GGTGTAGGATGACAAACTCC 185
CD14 NM_001174105 TGCCGCTGTGTAGGAAAGAAGCTA AGACGCAGCGGAAATCTTCATCGT 182
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idium bromide staining. U937 (ATCC, VA; CRL1593.2)
cells treated with or without tumor necrosis factor
(TNF)-α or LPS were positive controls. H2O was used
in place of template cDNA as a negative control and in-
cluded in each experiment.
Real-time polymerase chain reaction for TLR4
responsiveness
To compare polyp, scar, and normal (T21 & T59) VFF
production of TLR4 after direct ligand stimulation, we
treated cells with or without LPS. IL-1 receptor type I
(IL-1R1) mRNA was also measured to determine its
effects with LPS stimulation because autocrine IL-1β sig-
naling can induce NF-ĸB and enhance IL-8 secretion
[17]. FastStart DNA Master SYBR Green I kit (Roche)
with the LightCycler System was used to quantify sam-
ples as previously described [6,16]. Amplification of β-
actin was used as an internal control. Amplification
efficiencies of target and reference genes were assessed
by LightCycler software and specificity of each pair of
primers was confirmed by melting curves. A diluted
PCR product was used to assess the PCR replication effi-
ciency for all genes. U937 cells were used as positive
controls as described above at the same concentration of
total RNA as VFF. Standard curves were derived to
quantify gene expression and concentrations were nor-
malized to β-actin housekeeping gene.
Immunocytochemistry for NFκB translocation
To determine the functionality of TLR4 in VFF, we mea-
sured the nuclear translocation of RelA (NF-ĸB subunit
p65) after LPS induction in accord with previous studies
[18]. Rel A (p65) contains a transcriptional activation
domain in the carboxyl terminus of the protein neces-
sary for gene activation [19]. Normal (T21 and T59),
polyp, and scar VFF were seeded at 1.5 × 105 per wellinto 12 well plates (Becton Dickinson Labware) con-
taining sterile glass cover slips (Fisherbrand, 15CIR-
1D; Fisher Scientific, Pittsburg, PA). Cover slips were
incubated with DMEM-10% FBS twenty-four hours
prior to improve cell adherence. U937 cells stimulated
with 32 nM TPA (phorbol, 12-myristate, 13 Acetate)
for 48 hrs to induce monocyte/macrophage differenti-
ation (cell adhesion) were used as controls with and
without LPS stimulation. After six hours of incuba-
tion, fibroblasts were serum starved for twenty-four
hours to synchronize the cell cycle at G0 [20]. Cells
were then stimulated by adding DMEM-10% FBS sup-
plemented with 5 μg/ml LPS for 30 and 45 minutes.
These time points were chosen to ascertain the appro-
priate activation kinetics with LPS [21]. Cover slips
were then washed with phosphate buffered saline
(PBS; Sigma-Aldrich) and fixed with 4.0% formaldehyde
(Polysciences, Inc., Warrington, PA) for 30 minutes. Cells
were then washed with wash buffer (PBS- 0.1% Triton X-
100 [Sigma-Aldrich]) and permeabilized with 0.5% Triton
X-100 in PBS. After 5 minutes, cells were incubated with
blocking buffer (PBS, 1% bovine serum albumin [BSA], 1%
gelatin, 10% goat serum; all from Sigma-Aldrich) for
30 min. Cells were then incubated with anti-p65 rabbit
polyclonal IgG diluted 1:100 for 60 min (Santa Cruz Bio-
technology, USA) followed by incubation with fluorescein
isothiocyanate (FITC) conjugated goat anti-rabbit second-
ary antibody diluted at 1:200 (Invitrogen, Life Technolo-
gies, Grand Island, NY). After 60 minutes, cover slips
were washed and mounted to glass slides (Premium,
Fisher Scientific) with Vector aqueous anti-fade fluores-
cent medium with 4′,6-diamidino-2-phenylindole (DAPI;
Vectashield; Vector Laboratories, Burlingame, CA). All
procedures were performed at room temperature. Second-
ary antibody alone was run as a negative control.
Images were captured using a Nikon Eclipse E600 Epi
Flourescence inverted microscope (Nikon, Tokyo, Japan)
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presence of NF-ĸB (green) and nuclear staining (blue) at
the same exposure time (green 1/1.2 seconds, blue 1/40
excitation). To avoid biases with NF-κB staining, images
were taken by person unfamiliar to the study and se-
lected for analysis by viewing nuclear staining first to
identify regions of confluent cells. Data acquisition was
carried out with ImageJ software. Three images were
taken per slide. Total cell counts were determined for
each nuclear stain (DAPI) image by producing binary
versions of the image and using plugins to analyze and
automatically count each particle. Manual cell counts
were taken with the Fiji Crosshair plugin from unidenti-
fied images to determine NF-κB translocation. Cells
were considered NF-κB positive if bright green fluores-
cence was localized in the nucleus. Percentages of posi-
tive cells per image were determined by dividing the
number of NF-κB positive cells to the total cell count of
the image.Enzyme-linked immunosorbent assay (ELISA) for Cytokine
Secretion
To determine the direct downstream signaling effect
after TLR4 activation in VFF, we measured the produc-
tion of IL-8 pro-inflammatory cytokine after LPS stimu-
lation. VFF were seeded at near confluence 2 × 105 per
well into 12 well plates (Becton Dickinson Labware) to
control for growth kinetics. Following 24 hrs of serum
starvation, DMEM-10% FBS supplemented with or
without 5 μg/mL LPS was added to each well. After
8 hrs incubation, supernatants were removed and
stored at −80°C. Protein secretion levels were mea-
sured using an IL-8 ELISA according to the manufac-
turer’s protocol (Invitrogen, USA). Standard curves
were used to measure the quantity of each sample.
Non-stimulated cells and U937cells stimulated with
and without LPS were used as controls.Statistical analysis
All experiments were performed in triplicate and data
expresses the mean ± standard deviation (SD). One-way
analysis of variance (ANOVA) was used to compare dif-
ferences in gene expression levels between cell type and
treatment group. A repeated measure ANOVA was used
to analyze differences in NF-κB expression between
group, day, and group by day interaction. If the F-test re-
vealed significant differences at the 0.05 level, pairwise
comparisons were used to determine statistical differ-
ences between samples (Fisher’s least squares means). A
Pearson correlation coefficient was used to analyze the
relationship between the mean of IL-8 expression and
the two NF-κB time points. A p-value of <0.05 was con-
sidered significant.Results
Differences between VFF constitutive expression of TLR
1–9
To determine patterns of TLR gene production during
steady state conditions and to confirm TLR4 accessory
molecule expression, cDNA from scar, polyp, T21, and
T59 VFF were amplified for target genes and analyzed
using gel electrophoresis. VFF demonstrated expression
of TLR1 through TLR6 and TLR9 with noticeable in-
creases in the product size of TLR5 and TLR6 in com-
parison to all other receptors (Figure 1). No noticeable
product is present for TLR7 in normal VFF samples,
however a faint expression is appreciated with scar and
polyp VFF. TLR8 is also absent in T21 normal VFF and
only a faint expression noted in T59, scar, and polyp
VFF. All VFF expressed similar MD2 and CD14 tran-
scription levels (Figure 2).
Differences in VFF gene expression after stimulation with
TLR4 ligand
To characterize if TLR4 and IL-1R1 gene expression is
susceptible to LPS stimuli, we treated cells for 24 hrs
and analyzed them with RT-PCR. Concentrations for
each gene were determined by relative standard curves.
Results were normalized to the housekeeping gene by
calculating the ratio of the target gene to the housekeep-
ing gene. Data is presented in Figure 3 as fold-change.
Stimulation with LPS did not affect VFF constitutive ex-
pression of TLR4 gene. However, differences in TLR4
expression were found across types of VFF. Polyp VFFs
were found to have statistically higher TLR4 gene in
comparison to all other VFF (T21 and scar p < 0.0001;
T59 p < 0.001). T59 VFF also demonstrated statistically
higher expression in comparison to T21 (p < 0.0001) and
scar VFF (p < 0.001). LPS induced TLR4 ligation altered
VFFs expression of IL-1R1 gene, which is an important
regulatory mechanism of the inflammatory response.
Normal T21 and T59 VFF expressed significantly higher
levels of IL-1R1 after LPS stimulation in comparison to
similar conditions with scar (p < 0.01) and polyp VFF
(p < 0.0001). Significant decreases in IL-1R1 gene were
also found when polyp (p < 0.0001) and scar (p < 0.05)
were treated with LPS in comparison to controls.
LPS stimulated sustained upregulation of NF-ĸB in Polyp
and Scar VFF
To confirm the functional activation of TLR4 ligation,
NF-ĸB nuclear translocation was measured by assessing
p65 protein expression in the nucleus after 30 and 45 -
minutes of LPS stimulation. Results are presented in
Figures 4 and 5. T21 (p = 0.01), scar (p < 0.0001), and
polyp VFF (p < 0.0001) had a statistically higher percent-
age of p65 positive nuclei after 30 minutes of LPS-
induction compared to non-stimulated controls whereas
Figure 1 Constitutive mRNA expression of TLR 1 to 9 in VFF. Polymerase chain reactions showed that scar, polyp, and normal (T21 and T59)
VFF expressed TLR 1 to 6, TLR8, and TLR9 genes during steady state conditions. Amplification of β-actin was used as an internal control. Appropriate
sized DNA band for each gene product was determined by 100 bp ladder. Panels depict individual VFF and the PCR product of each TLR is displayed
in lanes marked 1 through 9.
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Nuclei with p65 staining were significantly greater in
T59 normal VFF (p < 0.02), scar (p < 0.01), and polyp
(p < 0.01) conditions at 45 min post-LPS compared to
their non-stimulated controls. No significant differences
were found 45 minutes post LPS with T21 VFF. Tem-
poral differences were observed with polyp and scar
VFF, demonstrating increased percentage of p65 positive
nuclei (p < 0.0001) after 45 minutes of LPS stimulation
in comparison to the 30 minute time point. No temporal
differences were seen with normal VFF.
Influence of TLR4 ligation on cytokine expression
To determine the downstream effects of TLR4 ligand ac-
tivation, the secretion of IL-8 an acute pro-inflammatory
cytokine well established to be induced by NF-κB activa-
tion with LPS in fibroblasts was measured after LPSFigure 2 Constitutive mRNA expression of TLR4 accessory molecules
normal (T21 and T59) VFF expressed MD-2 and CD14 mRNA. Appropriate s
ladder. U937 cells were used as a positive control.stimulation for 8 hours [22,23]. Results presented in
Figure 6. After LPS induction, VFF derived from polyp,
scar, and normal (T21 and T59) tissue demonstrated a
significant upregulation in IL-8 expression (p < 0.0001)
in comparison to untreated controls. Across LPS treated
conditions, scar VFF demonstrated statistically higher
expression of IL-8 in comparison to polyp, T21, and T59
VFF (p < 0.0001). Polyp VFF exhibited significantly higher
levels of IL-8 expression after LPS stimulation in compari-
son to similar conditions with T21 and T59 VFF
(p < 0.0001). T59 VFF also secreted significantly more
IL-8 in comparison to T21 VFF (p < 0.02).
Relationship between NF-ĸB activation and downstream
cytokine secretion levels
To characterize the correlation of VFF activation after
LPS stimulation, we compared the mean percentage ofin VFF. Polymerase chain reactions showed that scar, polyp, and
ized DNA band for each gene product was determined by 100 bp
Figure 3 Comparison of normal, scar, and polyp VFF gene expression after LPS stimulation. Cells were treated with 5 μg/mL LPS for
24 hrs. RNA was subsequently extracted, converted into cDNA, and then analyzed for (A) TLR4 and (B) IL-1 receptor 1 gene expression using
RT-PCR. Amplification efficiencies of target and reference genes were assessed by LightCycler software. Standard curves were derived to quantify
gene expression and concentrations were normalized to β-actin housekeeping gene. Letters represent a statistical significance of p < 0.05 when
compared to (a) T21 (b) T59 (c) scar (d) polyp. *represents differences within cell type with (w/) LPS compared to without (w/o) LPS.
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percentage of positive nuclei with VFF (polyp, scar, and
normal) after 30 minutes of LPS activation significantly
correlated to IL-8 secretion (0.844, p < 0.01). No signifi-
cant associations were noted at the 45 minute time point
(0.601, p = 0.115).
Discussion
The larynx is located at the crossing of the respiratory
and gastrointestinal systems exposing the vocal folds
to a diverse repertoire of microorganisms. During de-
cline of epithelial barrier function [24-26] (e.g. reflux,
dehydration, phonotrauma), microflora on the luminalFigure 4 Vocal fold fibroblasts NF-κB translocation into the nucleus. N
cells and stimulated with or without 5 μg/ml of LPS for 30 min (A) or 4
nucleus and nucleic acids. Data is graphed as the mean of the expressi
significance of p < 0.05 when comparing (a) T21 (b) T59 (c) scar (d) poly
and 45 min time points compared within treatment groups. *p < 0.05 re
without (w/o) LPS within each cell type.surface of the vocal fold may permeate the epithelium
and activate an innate immune response in the lamina
propria. TLRs are critical components to this re-
sponse, quickly detecting the conserved molecular
patterns on microbial surfaces (PAMPs), which signals
an antimicrobial defense (i.e. cytokines, phagocytes,
complement cascade) and controls the initiation of the
adaptive immune response. Recent evidence has dem-
onstrated that fibroblasts from other areas of the body
can directly contribute to innate immune response by
producing functional TLRs [11,12,27]. Since fibro-
blasts are the most prominent cells in the vocal fold
lamina propria and likely one of the first to encounterormal, scar, and polyp VFF were seeded on cover slips at 1.5 × 105
5 min (B). Cells were stained for NF-κB p65 translocation into the
on % of total cells counted ± SD. Letters represent a statistical
p across similar conditions. T represents differences between 30
present differences within cell type with (w/) LPS compared to
Figure 5 LPS stimulated upregulation of NF-ĸB in VFF. Scar and polyp vocal fold fibroblasts (VFF) stimulated with lipopolysaccharide (LPS)
for 45 minutes had higher percentage of NF-κB activation as detected by immunocytochemistry. NF-κB p65 translocation into the nucleus was
determined by immunofluorescence. The first column denotes normal (T21 & T59), scar, and polyp VFF baseline percentage levels without LPS
and second column shows levels after LPS stimulation.
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tion patterns and their function in response to a
known immunologic adjuvant is essential. Overall, our
results are novel as they demonstrate that human VFF
from normal and pathologic tissue present marked dif-
ferences in response to inflammatory stimuli.
Several cell types found in soft tissue express TLRs
genes and their accessory molecules, including dermal fi-
broblasts, endothelial, keratinocytes, epithelial, monocytes,
macrophages, and dentritic cells [10,12,27,28]. However,
because regions of the body with higher exposure to exter-
nal environment (i.e. lung, gastrointestinal tract) have
been shown to exhibit increased TLR mRNA [29,30], pat-
terns of TLR expression may differ across cell source. The
continuous exposure to pathogens and commensal micro-
organisms in the upper respiratory tract, which includesthe vocal folds, would suggest the need for TLR signaling
to maintain homeostasis. In the present study, we found
that all VFF constitutively expressed TLR1 to 6, TLR9, and
accessory molecules CD14 and MD2 genes, which are
needed to directly recognize bacteria, fungi, and viruses.
To our knowledge this is the first report of TLR and ac-
cessary molecule expression specific to the vocal folds.
Further investigation is necessary to determine their po-
tential role in regulating normal vocal fold homeostasis.
Given that exogenous and endogenous ligands are cap-
able of activating TLRs, tight regulation of these signal
pathways is vital. Our findings demonstrated that TLR4
gene expression was highest in fibroblasts derived from
polyps irrespective of LPS stimulation. It has been hy-
pothesized that vocal fold polyps are caused by the in-
flammatory response to vascular injury [31] and are
Figure 6 Downstream cytokine effects of TLR4 ligand
activation. Vocal fold fibroblasts (VFF) exhibited increased
expression of IL-8 after TLR4 activation. Polyp, scar, T21 and T59 VFF
were seeded in 12-well plates at 2 × 105 cells/well. After 8 hrs of
stimulation with 5 μg/ml of LPS, cell culture supernatants were
analyzed for IL-8 expression levels. Data is graphed as the mean
concentration (pg/ml) ± SD. Numbers represent a statistical
significance of p < 0.001 when compared to (a) T21 (b) T59 (c) scar (d)
polyp. *p < 0.05 represent differences within cell type with (w/) LPS
compared to without (w/o) LPS within each cell type.
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gram-negative bacteria [1]. Under these pathologic con-
ditions, surrounding cells can undergo damage or stress,
as the environment is enriched with inflammatory media-
tors (i.e. COX-2, HIF-1α) [32,33], proteases (MMP-2 ,-9)
[33], and ECM proteins (i.e. fibronectin, decorin) [31,34,35]
that can produce endogenous ligands and subsequently ac-
tivate TLRs (i.e. TLR2 or TLR4). Thereby, altering down-
stream signaling and influencing the inhibitory mechanisms
that are in place to protect against persist inflammation
[12]. TLR4 profiles could be used to distinguish vocal fold
disorders with similar macroscopic appearances (i.e. reinke’s
edema, polyp, cyst), which are known to be difficult to clin-
ically ascertain [36]. However, a limitation of our study is
the lack of biologic replicates of human vocal fold samples.
Therefore, confirmation of these findings is necessary both
amongst similar inflammatory vocal fold lesions and in vivo
with multiple donors.
Resolution of inflammation requires rapid induction
and resolution of NF-ĸB after LPS signaling, to control
the transcription of inflammatory genes needed to fight a
bacterial infection. Innate immune cells (i.e. macrophages)
exhibit peak NF-ĸB activation after thirty minutes that
quickly drops off during subsequent time points [22]. In
contrast, fibroblasts have been found to exhibit delays in
NF-ĸB activation leading to peaks at later time points
[21]. This is likely associated to the need for additional
adaptor molecules i.e. MyD88 and TIR-containing adaptor
molecules (Mal/TIRAP) during signaling [22]. In our
study, scar and polyp VFF physiologic response to LPS re-
sulted in a higher percentage of NF-ĸB activated cells incomparison to the minimal responses found with normal
VFF. Furthermore, when polyp and scar VFF were stimu-
lated with LPS they exhibited a down regulation of IL-1R1
mRNA, which may suggest that the observed effects of
NF-ĸB and IL-8 was produced in response to TLR4
ligation as opposed to autocrine signaling stimulation by
IL-1β. These findings demonstrate that VFF from patho-
logic tissue respond more robustly to LPS stimulation as
indicated by persistent increases in NF-ĸB activation and
IL-8 secretion. It is known that fibroblasts taken from
pathologies exhibit unique phenotypic characteristics [37]
and therefore, differences found may show the potential
education of fibroblasts in polyp and scar vocal folds.
From our work it is unclear if the responsiveness to LPS is
due directly to NF-ĸB activity. NF-ĸB overactivation has
been implicated in several inflammatory diseases, includ-
ing rheumatoid arthritis or atherosclerosis [38]. Targeting
NF-ĸB activity with steroids is a commonly used clinical
approach in Otolaryngology Head and Neck Surgery to
treat inflammatory disorders, but there is disagree-
ment in its effectiveness [39-42]. Our results would
suggest that glucocorticoids may only be effective in
the presence of inflammatory stimuli in the vocal fold
since there is no evidence for constitutive activation of
NF-ĸB in the four donor cell lines studied. However,
given that steroids can adversely affect wound healing,
treatments with steroids may potentially delay the in-
flammatory response against the insulting agent (i.e.
LPS). Further investigation into the effectiveness of
steroids in down regulating VFF inflammatory respon-
siveness is necessary and warranted before clinical rec-
ommendations could be made.
Impaired TLR4 expression can alter the signaling cas-
cade, leading to a persistent pathologic state. Down-
stream effects of LPS signaling resulted in elevated IL-8
expression in polyp and scar VFF, which strongly corre-
lated with the percentage of NF-ĸB activated cells after
30 minutes. Scar VFF exhibited the highest IL-8 cytokine
expression overall, which warrants further discussion.
One would speculate that fibroblasts derived from vocal
fold polyps would be more likely to produce higher
amounts of IL-8 due to the inflammatory nature of the
pathology [32,33], as well as the higher constitutive
levels of TLR4 gene and greater percentage of NF-ĸB ac-
tivated cells that we observed in the current study.
These downstream discrepancies suggest different regu-
latory proteins may be controlling the expression in each
cell type, possible mediating the disorder. We previously
reported that co-culturing polyp VFF with activated
macrophages resulted in significantly more IL-8 secre-
tion than similar co-cultures conditions with scar VFF
[8]. These studies lend further support to the notion that
fibroblasts isolated from scar or polyp lesions undergo
pathology-induced education.
King et al. Journal of Inflammation  (2014) 11:42 Page 9 of 10Conclusion
The results of this study demonstrate that human VFF
from pathologic tissue present marked differences in
response to inflammatory stimuli. This work outlines a
rational paradigm for clinical assessment of the TLR4
pathway not only to improve clinical diagnosis, but also
to expand treatment options by analyzing its effects on
the resolution of inflammation.
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